Science
Mechanism of Action
Arnica operates through a multi-pathway approach: it inhibits the NF-κB signaling pathway to mitigate inflammatory responses and acts as a vasoactive agent to clear heme by-products in the microcirculation. Furthermore, it stimulates the differentiation and lipid accumulation of subcutaneous preadipocytes, resulting in a localized volumizing effect.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 Clinical trials demonstrate that 1% Arnica extract significantly increases subcutaneous adipose tissue volume, effectively reducing wrinkle depth and enhancing lip fullness.
- 02 Traditional dermatological data supports concentrations of 20-25% in tincture form for the rapid resolution of subcutaneous bruising and localized inflammation.
Transparency
Dusting Analysis
Many formulations include Arnica at negligible levels (below 0.1%) for marketing claims. To achieve measurable volumizing or anti-inflammatory results, a minimum concentration of 1% is required based on recent clinical data.
The Formula
Formulation
Stability
Highly thermolabile; exposure to temperatures exceeding 40°C during formulation can degrade sensitive phenolic compounds. Must be integrated during the cool-down phase.
Synergies
- Vitamin K
- Bromelain
- Hyaluronic Acid
Conflicts
- Broken skin/Open wounds
- Known Asteraceae allergies
Safety
Safety Profile
Contains helenalin, a sesquiterpene lactone that may cause contact dermatitis in sensitized individuals. Use is contraindicated on broken or abraded skin.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance botanical for targeted volume restoration and microcirculation management, provided it is formulated at active concentrations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources